Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Oral toxoid vaccine under development by OraVax

June 7, 1996

Commencement of SYNSORB Cd phase I trial expected

June 7, 1996

Centocor's CenTNF sees positive results

May 31, 1996

Nitto Boseki claims serine protease inhibitors

May 24, 1996

Tobishi CCK-A antagonists for pancreatitis

May 24, 1996

TravelGAM clinical results presented at ASM meeting

May 24, 1996

Orphan Medical obtains European marketing rights for Colomed

May 24, 1996

5-HT4 antagonist LY-353433: Potential treatment for GI disorders

May 24, 1996

Lexirin cleared to enter phase I

May 17, 1996

Potential pancreatitis treatments reported by Snow Brand

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 3, 2025.
Researchers arm CAR T cells to fight solid tumors
BioWorld
Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the...
Bioversys, Shionogi in CHF529M lung infection collaboration
BioWorld Science
Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on...
Medtronic receives CE mark for its Vitalflow ECMO system
BioWorld MedTech
Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...